There are 2789 resources available
1380P - Phase (Ph) II study of zanidatamab + chemotherapy (chemo) in first-line (1L) HER2 expressing gastroesophageal adenocarcinoma (GEA)
Presenter: Geoffrey Ku
Session: ePoster Display
1485P - Identification of novel protein biomarkers for FOLFIRINOX-based chemotherapy response in advanced pancreatic adenocarcinoma using patient omics and Bayesian AI
Presenter: A. Moser
Session: ePoster Display
1383P - Phase I study of the irreversible FGFR inhibitor futibatinib in Japanese patients with advanced solid tumors: Updated dose expansion results and activity in gastric cancer
Presenter: Yasutoshi Kuboki
Session: ePoster Display
1384P - DKN-01 in combination with tislelizumab and chemotherapy as a first-line therapy in unselected patients with advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial
Presenter: Samuel Klempner
Session: ePoster Display
1555TiP - A phase II single-arm study of pembrolizumab plus lenvatinib in previously treated classic Kaposi sarcoma (CKS): The PULSAR trial
Presenter: Alice Indini
Session: ePoster Display
1568P - Clinical and laboratory outcomes of solid cancer patients reinfected with SARS-CoV-2
Presenter: Ozan Yazıcı
Session: ePoster Display
1494P - Anxiety and depression during the COVID-19 pandemic in newly diagnosed advanced cancer patients
Presenter: Berta Obispo
Session: ePoster Display
1495P - Anxiety and depression in cancer patients receiving oncology treatment: Associated factors
Presenter: Eleni Arvanitou
Session: ePoster Display
1571P - COVID-19 positivity rates in patients with an active cancer diagnosis in the University of California Cancer Consortium
Presenter: Julian Hong
Session: ePoster Display
1392P - Submucosal versus subserosal approaches toward optimized indocyanine green tracer-guided lymphadenectomy for gastric cancer: A randomized clinical trial
Presenter: Qi-Yue Chen
Session: ePoster Display